Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer

European Journal of Nuclear Medicine

Volumn 25, Issue 9, 1998, Pages 1255-1260

  Adams, Stefan ^a   Baum, Richard P ^a   Stuckensen, Tankred ^a   Bitter, Klaus ^a   Hör, Gustav ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Conventional imaging modalities; Fluorine 18 fluorodeoxyglucose; Head and neck cancer; Squamous cell carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOPROMIDE; DIAGNOSTIC AGENT; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; CERVICAL LYMPH NODE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; ENDOSCOPY; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; SQUAMOUS CELL CARCINOMA; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; HEAD AND NECK TUMOR; LYMPH NODE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

CARCINOMA, SQUAMOUS CELL; DIAGNOSTIC IMAGING; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031595329     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050293     Document Type: Article

References (38)

1. Parker SL, Tong T, Bolden S, et al. Cancer statistics 1996. CA Cancer J Clin 1996; 46: 5-27.
2. Vokes EE, Weichselbaum RR, Lippman SM, et al. Head and neck cancer. N Engl J Med 1993; 328: 184-194.
3. Forastiere AA. Overview of platinum chemotherapy in head and neck cancer. Semin Oncol 1994; 21: 20-27.
4. Panje WR, Namon AJ, Vokes E, et al. Surgical management of the head and neck cancer patient following concomitant multimodality therapy. Laryngoscope 1995; 105:97-101.
5. Aisner J, Jacobs M, Sinabaldi V, et al. Chemoradiotherapy for the treatment of regionally advanced head and neck cancers. Semin Oncol 1994; 21: 35-44.
6. Sham JS, Choy D. Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br J Radiol 1990; 63: 51-58.
7. Snow GB, Annanyas AA, Van Slooten EA, et al. Prognostic factors of neck metastases. Clin Otolaryngol 1982; 7: 185-192.
8. Whitehurst JO, Droulias CA. Surgical treatment of squamous cell carcinoma of the oral tongue. Arch Otolaryngol 1987; 103: 212-215.
9. Ensley JF, Maciorowski Z, Hassan M. Cellular DNA content parameters in untreated and recurrent squamous cell cancers of the head and neck. Cytometry 1989; 10: 334-338.
10. Johnson GS, Williamson KD, Cramer MM, et al. Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded sections: comparison with malignancy grading. Cytometry 1985; 6: 461-470.
11. Brinkmann G, Brix F, Beigel A, Sonography, CT, MR in soft part growths in the head and neck region. Röntgenblätter 1990: 43: 58-64.
12. van den Brekel MWM, Casteljins JA, Stel HV, et al. Cervical lymph node metastases: assessment of radiologic criteria. Radiology 1981; 180: 457-461.
13. Strauss LG, Ponti PS. The application of PET in clinical oncology. J Nucl Med 1991; 32: 623-648.
14. Jabour BA, Choi Y, Hoh CK, et al. Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993; 186: 27-35.
15. Lindholm P, Minn H, Leskinen-Kallio S, et al. Influence of the blood glucose concentration on FDG uptake in cancer - a PET study. J Nucl Med 1993; 34: 1-6.
16. Hermanek P, Sobin LH. TNM classification of malignant tumours, 4th edn, 2nd revision. Berlin Heidelberg New York: Springer, 1992.
17. Leicher-Düber A, Thelen U, Bleier R. Palpation and sonography of metastases of the cervical lymph nodes. Röntgenblätter 1989; 42: 195-198.
18. Dooms GC, Hricak H, Crooks LE, et al. Magnetic resonance imaging of the lymph nodes: comparison with CT. Radiology 1984; 153: 719-728.
19. Mafee MF, Campos M, Raju S, et al. Head and neck: high field magnetic resonance imaging versus computed tomography. Otolaryngol Clinic North Am 1988; 21: 513-546.
20. Gritzmann N, Czembriek H, Hajek P, et al. Sonographic bei cervikalen Lymphknotenmetastusen. Radiologie 1987; 27: 118-122.
21. Archer CR, Yeager VL. Computed tomography of laryngeal cancer with histopathological correlation. Laryngoscope 1982; 92: 1173-1180.
22. Zheng G, Zeng Q, Wu P, Yuan CM. Computed tomography in the management of nasopharyngeal carcinoma. Clin Radiol 1989; 40: 25-29.
23. Mancuso AA, Harnsberger HR, Muraki AS, et al. Computed tomography of cervical and retropharyngeal lymph nodes: normal anatomy, variants of normal, and applications in staging head and neck cancer. Part II. Pathology. Radiology 1983; 148: 715-723.
24. Moreau P, Goffart Y, Collignon J. Computed tomography of metastatic cervical lymph nodes. A clinical, computed tomographic, pathologic correlative study. Arch Otolaryngol Head Neck Surg 1980; 116: 1190-1193.
25. Helmberger R, Jager L, Grevers G, et al. Computerized tomography of malignancies of the oral cavity, the oropharynx and hypopharynx and invasiveness. Radiologe 1996; 36: 193-198.
26. Stevens MH, Harnsherger HR, Mancuso AA, et al. Computed tomography of cervical lymph nodes. Staging and management of head and neck cancer. Acta Otolaryngol 1985; 111: 735-739.
27. Eichhorn T, Schroeder HG, Glanz T, et al. Historically controlled comparison of palpation and sonography in the diagnosis of cervical lymph node metastases. Laryngol Rhinol Otol 1987; 66: 266-274.
28. van den Brekel MW, Castelijns JA, Snow GB. Imaging of cervical lymphadenopathy. Neuroimaging Clin North Am 1996; 6: 417-434.
29. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI, endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995; 36: 1747-1757.
30. Kubota R, Yamada S, Kubota K, et al. Intratumoural distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiographic comparison with FDG. J Nucl Med 1992; 3: 1972-1980.
31. Haberkorn U, Strauss LG, Reisser C, et al. Glucose uptake, perfusion, and cell proliferation in head and neck tumours: relation of positron emission tomography to flow cytometry. J Nucl Med 1993; 34: 12-17.
32. Field JK, Lamonthe A, Spandidos DA. Clinical relevance of oncogene expression in head and neck tumours. Anticancer Res 1986; 6: 595-600.
33. Field JK, Spandidos DA, Stell PM, et al. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene 1989; 4: 1463-1468.
34. Kubota R, Kubota K, Yamada S, et al. Methionine uptake by tumour tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995 36: 484-492.
35. Braams JW, Pruim J, Nikkels PGJ, et al. Nodal spread of squamous cell carcinoma of the oral cavity detected with PET-tyrosine, MRI and CT. J Nucl Med 1996; 37: 897-901.
36. 11C-methionine in breast cancer studied by PET: an association with the size of S-phase fraction. Br J Cancer 1991; 64: 1121-1124.
37. Leskinen-Kallio S, Nagren K, Lehikoinen P, et al. Carbon-11-methionine and PET is an effective method to image head and neck cancer. J Nucl Med 1992; 33: 691-695.
38. Valk PE, Pounds TR, Tesar RD, Hopkins DM, Haseman MK. Cost-effectiveness of PET imaging in clinical oncology. Nucl Med Biol 1996; 23: 737-743.